Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment

Journal of Clinical Microbiology

Volumn 45, Issue 8, 2007, Pages 2734-2736

  Houzé, Sandrine ^a,b   Munier, Aline ^a,d   Paoletti, Xavier ^b   Kaddouri, Halima ^a   Ringwald, Pascal ^c   Le Bras, Jacques ^a  

^a EA 209   (France)

^b BICHAT HOSPITAL   (France)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; DIHYDROARTEMISININ; MEFLOQUINE;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG SENSITIVITY; IC 50; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMODIUM FALCIPARUM; PLATE COUNT; PRIORITY JOURNAL; SHELF LIFE; STORAGE; TEMPERATURE MEASUREMENT;

ANTIMALARIALS; CULTURE MEDIA; DRUG STABILITY; DRUG STORAGE; PARASITIC SENSITIVITY TESTS;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 34548058651     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00479-07     Document Type: Article

References (18)

1. Akoachere, M., K. Buchholz, E. Fischer, J. Burhenne, W. E. Haefeli, R. H. Schimer, and K. Becker. 2005. In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob. Agents Chemother. 49:4592-4597.
2. Basco, L. K. 1993. Halofantrine resistance in African countries. Lancet 341:1283.
3. Basco, L. K. 2004. Molecular epidemiology of malaria in Cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 70:474-480.
4. Borrmann, S., R. K. Binder, A. A. Adegnika, M. A. Missinou, S. Issifou, M. Ramharter, W. H. Wernsdorfer, and P. G. Kremsner. 2002. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans. R. Soc. Trop. Med. Hyg. 96:660-663.
5. Brasseur, P., P. Bitsindou, R. S. Moyou, T. A. Eggelte, G. Samba, L. Penchenier, and P. Druilhe. 1993. Fast emergence of Plasmodium falciparum resistance to halofantrine. Lancet 341:901-902.
6. Brockman, A., S. Singlam, L. Phiaphun, S. Looareesuwan, N. J. White, and F. Nosten. 2004. Field evaluation of a novel colorimetric method double-site enzyme-linked lactate dehydrogenase immunodetection assay to determine drug susceptibilities of Plasmodium falciparum clinical isolates from northwestern Thailand. Antimicrob. Agents Chemother. 48:1426-1429.
7. Daher, W., C. Biot, T. Fandeur, H. Jouin, L. Pelinski, E. Viscogliosi, L. Fraisse, B. Pradines, J. Brocard, J. Khalife, and D. Dive. 2006. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure. Malaria J. 5:11.
8. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
9. Druilhe, P., A. Moreno, C. Blanc, P. Brasseur, and P. Jacquier. 2001. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 64:233-241.
10. Duraisingh, M. T., P. Jones, I. Sambou, L. von Seidlein, M. Pinder, and D. C. Warhurst. 1999. Inoculum effects leads to overestimation of in vitro resistance for artemisinin derivatives and standard antimarials: a Gambian field study. Parasitology 119:435-440.
11. Feng, X. P., and D. Q. Liu. 2003. Factors affecting the in vitro microtest for drug sensitivity of Plasmodium falciparum. Zhongguo. Ji. Sheng. Chong. Xue. Yu. Ji. Sheng. Chong. Bing. Za. Zhi. 21:234-237.
12. Kaddouri, H., S. Nakache, S. Houzé, F. Mentré, and J. Le Bras. 2006. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from Africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration. Antimicrob. Agents Chemother. 50:3443-3449.
13. Kayumba, P. C., P. G. Risha, D. Shewiyo, A. Msami, G. Masuki, D. Ameye, G. Vergote, J. D. Ntawukuliryayo, J. P. Remon, and C. Vervaet. 2004. The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution. J. Qin. Pharm. Ther. 29:331-338.
14. Noedl, H., W. H. Werndorsfer, R. S. Miller, and C. Wongsrichanalai. 2002. Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob. Agents Chemother. 46:1658-1664.
15. Syre, H., S. Phyu, P. Sandven, B. Bjorvatn, and H. M. S. Grewal. 2003. Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J. Qin. Microbiol. 41:5173-5177.
16. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
17. World Health Organization. 2001. WHO test plates for in vitro assessment of antimalarial drug susceptibility. World Health Organization, Geneva, Switzerland. www.who.int/malaria/rbm/Attachment/20041108/catalogPenang. pdf.
18. World Health Organization. 2001. In vitro micro-test (Mark III) for the assessment of the response of Plasmodium falciparum to chloroquine, mefloquine, quinine, amodiaquine, sulfadoxine/pyrimethamine and artemisinin. CDT/MAL/97.20 Rev. 2. World Health Organization, Geneva, Switzerland.